Skip to main content
. 2007 Oct;61(10):1671–1676. doi: 10.1111/j.1742-1241.2007.01500.x

Figure 2.

Figure 2

Percentage of patients requiring titration steps to achieve stabilisation of OROS® hydromorphone dose (n = 318)